Product category:
Polymerase chain reaction (PCR)
News Release from: Chimera Biotec
Edited by the Laboratorytalk Editorial
Team on 04 May 2007
AbD Serotec and Chimera Biotec extend
agreement
Companies agree to co-market the rapid generation of monoclonal antibodies by AbD Serotec and Chimera Biotec's complementary Imperacer assay technology for ultra-sensitive antigen detection
Each company will offer the services of the other to its customers throughout the world-wide market The Imperacer technology combines the advantages of flexible and robust protein detection through Elisa with the exponential signal amplification typical for PCR
This article was originally published on Laboratorytalk on 21 Mar 2005 at 8.00am (UK)
Related stories
Improve the sensitivity of Elisas 1000 times
Scientists benefit from an ultra-sensitive technology improving the existing assays by simply exchanging the fluorophor or enzyme labelled antibody by a DNA-antibody conjugate
Athletic doping gets 1000 times harder to hide
Steroids and other forms of illegal substance abuse are 1000 times easier to detect in athletes thanks to a new highly sensitive technology created by Chimera Biotec and German Sports University.
Imperacer uses antibody-DNA conjugates as a substitute for the antibody-enzyme conjugate used in Elisa.
Amplifying the conjugated marker-DNA typically results in a 100-10,000-fold increase in sensitivity over enzyme-linked assays.
Imperacer is currently used in human and veterinary diagnostics, bio-pharmaceutical research, biological defense, and in the food, beverage, and cosmetics industries.
It is used for a wide variety of highly sensitive analytic applications such as pharmaceutical R+D, first-in human studies, virus detection, prion analysis, pharmacokinetic studies, detection of toxins in food and beverages, and quality assurance for cosmetics.
AbD Serotec uses Hucal Gold, a proprietary recombinant antibody library technology to select antibodies against any given antigen in record time.
The process is performed entirely in vitro, and no laboratory animals are involved.
Pre-adsorption and intelligent counter-screening during the antibody generation process is used to drive the selection towards the unique epitopes on the antigen.
This allows the selection and purification of highly specific antibodies in just eight weeks.
Rapid monoclonal antibody generation service using Hucal Gold is offered worldwide to researchers both from academia and industry.
"The high sensitivity of the Imperacer system demands highly specific antibodies to be effective, and many of our customers are seeking such antibodies for these assays," commented Jan Detmers, business development manager of Chimera Biotec.
"We believe that the AbD Serotec process is ideal for rapidly generating antibodies with the specificity our customers need in order for us to be able to develop the best assay.".
• Chimera Biotec: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
